Lifecore Biomedical Stock (NASDAQ: LFCR) stock price, news, charts, stock research, profile.
Open | $5.08 |
Close | $5.20 |
Volume / Avg. | 162.62K / 298.08K |
Day Range | $5.08 - $5.36 |
52 Wk Range | 3.68 - 8.90 |
Market Cap | $160.67M |
P/E Ratio | 20.76 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 55 |
Short Interest | 15.38% |
Days to Cover | 6.17 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lifecore Biomedical (NASDAQ:LFCR) through any online brokerage.
Other companies in Lifecore Biomedical’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quanterix (NASDAQ:QTRX), Conduit Pharmaceuticals (NASDAQ:CDT) and ChromaDex (NASDAQ:CDXC).
Lifecore Biomedical has a consensus price target of $8.50.
The stock price for Lifecore Biomedical (NASDAQ: LFCR) is $5.2 last updated September 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Lifecore Biomedical.
Lifecore Biomedical’s Q4 earnings are confirmed for Monday, August 26, 2024.
There is no upcoming split for Lifecore Biomedical.
Lifecore Biomedical is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.